Huge gains made in breast cancer treatment thanks to Intrabeam® technology
An ongoing clinical trial using a new technology known as Intrabeam® is showing promising results in the treatment of breast cancer patients with low-risk recurrence at the Cedars Cancer Centre of the MUHC. The wand-like device, which is the first of its kind in Quebec, is used to administer a single dose of concentrated targeted radiation during tumour-removal surgery, causing minimal damage to the surrounding healthy tissue or organs. The procedure eliminates the need for post-surgery radiotherapy and reduces healthcare costs.
To read more: